Josh Brown, CEO of Ritholtz Wealth Management, joins CNBC's "Halftime Report" to reveal his favorite stocks in the market.

Cognizant (CTSH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Gilead is expected to enhance its efficiency through leveraging Cognizant’s expertise in AI and advanced technology ...

A US court has requested Cognizant to specify the nature of its trade secrets after Infosys denied the theft allegations, ...

The testimony of Srimanikandan Ramamoorthy, dubbed an ‘essential witness’ by the US Department of Justice, is critical, ...

Cognizant sued Infosys, accusing it of stealing secrets related to its US subsidiary TriZetto's healthcare insurance software ...

Morgan Stanley raised the firm’s price target on Cognizant (CTSH) to $80 from $75 and keeps an Equal Weight rating on the shares while ...

Cognizant will continue to support key enterprise areas such as global finance systems and human capital management.

Cognizant (CTSH) has announced an expansion of its longstanding relationship with biopharmaceutical leader Gilead Sciences (GILD) that aims to ...

TEANECK, N.J. - Cognizant Technology Solutions Corporation (NASDAQ:CTSH), a prominent player in the IT Services industry with ...

The row between the two IT services firms arose in August 2024 when Cognizant alleged that Infosys stole trade secrets of its software products used to process insurance claims in the healthcare ...

Cognizant partners with CrowdStrike to enhance enterprise security using AI-powered Falcon platform. Q4 results on Feb 5, ...